Back to Search
Start Over
Biodistribution of 18F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.
- Source :
- Journal of Nuclear Medicine; Dec2021, Vol. 62 Issue 12, p1-29, 29p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 01615505
- Volume :
- 62
- Issue :
- 12
- Database :
- Complementary Index
- Journal :
- Journal of Nuclear Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 154278530
- Full Text :
- https://doi.org/10.2967/jnumed.121.262500